📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia. (2013)

First Author: Cregg R

Attributed to: Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis - The International IBM Consortium Genetic Study funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s12017-012-8216-8

PubMed Identifier: 23292638

Publication URI: http://europepmc.org/abstract/MED/23292638

Type: Journal Article/Review

Volume: 15

Parent Publication: Neuromolecular medicine

Issue: 2

ISSN: 1535-1084